TY - CHAP
T1 - Application of bioassays/biosensors for the analysis of pharmaceuticals in environmental samples
AU - Valera, Enrique
AU - Babington, Ruth
AU - Broto, Marta
AU - Petanas, Salvador
AU - Galve, Roger
AU - Marco, Maria Pilar
N1 - Funding Information:
This work has been supported by the European Community (EC, VII. Food, Agriculture and Fisheries, and Biotechnology, KBBE2007-211326) and by the Ministry of Science and Innovation (Contract number CTQ2011-29163-C03-01). Nanobiotechnology for Diagnostics group (Nb4D) is a consolidated Grup de Recerca de la Generalitat de Catalunya and has support from the Departaments d’Universitats, Recerca i Societat de la Informació from the Generalitat de Catalunya (expedient 2009 SGR 1343). CIBER-BBN is an initiative funded by the VI National R&D&I Plan 2008–2011, Iniciativa Ingenio 2010, Consolider Program, and CIBER Actions and financed by the Instituto de Salud Carlos III with assistance from the European Regional Development Fund.
PY - 2013
Y1 - 2013
N2 - With the ever-increasing use of pharmaceuticals and the subsequent release into the environment comes the need for reliable detection methods. While the emphasis continues to be on chromatographic methods, every time, there are more and more biologically based assays being developed for the detection of pharmaceuticals in the environment. This chapter affords an overview of the currently available bioassays, biochemical assays, and biosensors focusing on the most commonly used pharmaceuticals-antibiotics, hormones, and analgesics. Bioassays rely on biological indicators, whether it be cells, tissues, or whole organisms, to evaluate an analyte according to its biological activity, whereas biochemical assays and biosensors incorporate biorecognition elements such as enzymes, proteins, or antibodies but the signal is enhanced by physical or chemical means. There has been more emphasis given on biosensors, especially immunologic sensors, for as the reader will appreciate, they show greater promise as alternatives to chromatography as they are fast, robust, specific, and quantifiable and may be performed on-site.
AB - With the ever-increasing use of pharmaceuticals and the subsequent release into the environment comes the need for reliable detection methods. While the emphasis continues to be on chromatographic methods, every time, there are more and more biologically based assays being developed for the detection of pharmaceuticals in the environment. This chapter affords an overview of the currently available bioassays, biochemical assays, and biosensors focusing on the most commonly used pharmaceuticals-antibiotics, hormones, and analgesics. Bioassays rely on biological indicators, whether it be cells, tissues, or whole organisms, to evaluate an analyte according to its biological activity, whereas biochemical assays and biosensors incorporate biorecognition elements such as enzymes, proteins, or antibodies but the signal is enhanced by physical or chemical means. There has been more emphasis given on biosensors, especially immunologic sensors, for as the reader will appreciate, they show greater promise as alternatives to chromatography as they are fast, robust, specific, and quantifiable and may be performed on-site.
KW - Bioassays
KW - Biochemical Assays
KW - Environmental residues
KW - Immmunosensors
KW - Pharmaceuticals
KW - Wastewater samples
UR - http://www.scopus.com/inward/record.url?scp=84888421447&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84888421447&partnerID=8YFLogxK
U2 - 10.1016/B978-0-444-62657-8.00007-0
DO - 10.1016/B978-0-444-62657-8.00007-0
M3 - Chapter
AN - SCOPUS:84888421447
T3 - Comprehensive Analytical Chemistry
SP - 195
EP - 229
BT - Comprehensive Analytical Chemistry
PB - Elsevier B.V.
ER -